Expand RFL Menu
RFL MENU

RFL Latest Press Releases

-- November 3, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL Globe Newswire 5:20 PM
Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference Globe Newswire 11:14 AM

-- October 29, 2026 --

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM
Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol Cyclo (remibetadex) for the Treatment of Niemann-Pick Disease Type C Globe Newswire 7:00 AM

-- October 27, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Rafael Holdings, Inc. - RFL Globe Newswire 6:42 PM

-- October 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL PRNewswire 10:02 AM

-- October 13, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL Globe Newswire 5:29 PM

-- October 8, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL PRNewswire 10:02 AM

-- October 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL Globe Newswire 5:08 PM

-- September 30, 2026 --

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC Study of Trappsol Cyclo in Niemann-Pick Disease Type C (NPC) Globe Newswire 7:00 AM

-- August 10, 2026 --

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage Globe Newswire 9:01 AM

-- June 11, 2026 --

Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results Globe Newswire 7:30 AM

-- June 10, 2026 --

Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC Study Evaluating Trappsol Cyclo for the Treatment of Niemann-Pick Disease Type C Globe Newswire 7:30 AM
Market Data Delayed 15 Minutes